Search

everythinglearnresearchcommunity

for

Search:↓

Irisin and GIP levels are not linked to BMI in women, regardless of PCOS status.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Clinical signs of excess male hormones and actual hormone levels in the blood do not always match in women with polycystic ovary syndrome.

Women with PCOS risk had normal height and blood tests but higher weight and common acne or hirsutism.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Differentiating PCOS from NCAH helps improve diagnosis and treatment.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Hirsutism in Afghan women varies by community, influenced by awareness, education, and socio-economic status.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

Androstenedione is better than testosterone for diagnosing PCOS in Indian women.

PSA can help diagnose high androgen levels in women.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

A woman was diagnosed with a rare adrenal gland cancer that did not show usual hormone-related symptoms.

Higher doses of oestradiol implants improve bone density in postmenopausal women.

The conclusion is that women under 35 should start fertility checks after 12 months of trying to conceive, women over 35 after 6 months, and women over 40 should start immediately. The checks should include ovulation status, reproductive tract structure, and male partner's semen evaluation.

More adolescent girls in urban areas of India have Polycystic Ovary Syndrome compared to those in rural areas.

A higher testosterone to dihydrotestosterone ratio may indicate worse metabolic health in women.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

The Free Androgen Index (FAI) is the best indicator of early hair loss in men before age 30.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

Bald men may have a lower risk of testicular cancer.

Iron deficiency is linked to hair loss in adolescents, especially females, in northern Sudan.